Diagnosing leptospirosis requires a combination of clinical suspicion, exposure history, and laboratory testing, because no single test reliably catches the infection at every stage. The disease mimics many other febrile illnesses, and the best diagnostic approach depends on how many days have passed since symptoms began. Blood-based molecular tests work best in the first week, while antibody tests become more reliable in the second week and beyond.
Why Leptospirosis Is Hard to Diagnose
The early symptoms of leptospirosis, including fever, chills, headache, and muscle pain, look nearly identical to dengue, malaria, hantavirus, and dozens of other tropical and subtropical infections. Severe calf pain and conjunctival suffusion (redness of the eyes without discharge, appearing around day three or four) are more distinctive clues, but many clinicians won’t encounter them regularly enough to recognize the pattern immediately.
The infection follows a biphasic course in some patients. The first phase lasts roughly three to nine days and presents as a nonspecific acute fever with muscle aches that can be intense enough to mimic an abdominal emergency. The second phase begins when the immune system starts producing antibodies and the bacteria shift from the bloodstream into the urine. This two-phase pattern is important because different diagnostic tests work during different windows.
PCR Testing: Best in the First Week
Molecular testing (PCR) detects bacterial DNA directly and is the most useful tool during the first seven to ten days of illness, when the bacteria are circulating in the blood and spinal fluid. One study estimated PCR sensitivity as high as 92 to 98 percent when blood samples were collected early in the disease course. After the first week, bacteria largely clear from the bloodstream, so PCR on blood becomes less reliable.
Urine is a different story. Leptospira bacteria appear in urine from the onset of symptoms and persist for at least three weeks, making urine the most reliable specimen for PCR across the full course of illness. If you’re being evaluated for leptospirosis and more than a week has passed since your symptoms started, a urine PCR is more likely to catch it than a blood draw alone.
The Microscopic Agglutination Test (MAT)
The MAT is considered the reference standard for confirming leptospirosis worldwide. It measures how strongly your antibodies react against a panel of different Leptospira strains. The catch is that it performs poorly on a single blood sample drawn early in the illness. A meta-analysis found that a single acute-phase MAT had a pooled sensitivity of just 14 percent, meaning it misses the vast majority of true infections when drawn too soon.
The test becomes far more powerful when paired samples are used: one drawn during acute illness and another two to six weeks later. A fourfold rise in antibody levels between those two samples is strong evidence of active infection. On a single sample, a titer of 800 or higher meets the CDC’s confirmatory threshold, while a titer of 1,600 or above is particularly suggestive of recent infection. Titers between 200 and 800 on a single sample are considered presumptive rather than confirmatory, and a follow-up draw is recommended.
Because the MAT requires maintaining live bacterial cultures and specialized expertise, it’s only available at reference laboratories. Results can take days to weeks, which limits its usefulness for guiding early treatment decisions.
Rapid Tests and IgM ELISA
For faster results, rapid diagnostic tests (lateral flow assays) and IgM ELISA tests detect antibodies your immune system produces in response to infection. These are more accessible than the MAT and can return results within hours rather than weeks.
Performance varies considerably. In a study comparing four rapid tests against the MAT as a reference, sensitivities ranged from 31 to 84 percent, while specificities were more consistent at 88 to 98 percent. The better-performing rapid tests picked up roughly four out of five true infections. IgM ELISA performed well in one study, with sensitivity around 97 percent and specificity around 99 percent, though these numbers can shift depending on timing and the population being tested.
Detection of IgM antibodies in an acute-phase blood sample counts as presumptive laboratory evidence under the CDC’s 2025 case definition. A positive rapid test in someone with compatible symptoms and a plausible exposure (flooding, freshwater contact, working with animals) is enough to classify a probable case and start treatment while waiting for confirmatory results.
Blood Work That Raises Suspicion
Routine lab tests can’t confirm leptospirosis on their own, but certain patterns help clinicians recognize it. In one study of hospitalized patients with severe disease, 41 percent had markedly elevated bilirubin (a marker of liver dysfunction), 36 percent had significantly elevated creatinine (indicating kidney damage), and 21 percent had very low platelet counts. Liver enzyme elevations were present in roughly a quarter of cases but tended to be modest compared to the dramatic bilirubin spikes, a pattern that helps distinguish leptospirosis from viral hepatitis.
This combination of kidney and liver dysfunction appearing together, sometimes called Weil’s disease in its severe form, is a hallmark. If you’re sick with a fever and your lab work shows simultaneous kidney injury, jaundice, and low platelets, leptospirosis should be high on the list, especially if you’ve had recent contact with potentially contaminated water or soil.
Imaging in Severe Cases
Chest X-rays and ultrasound aren’t used to diagnose leptospirosis directly but become important when the disease turns severe. Pulmonary involvement produces a characteristic pattern on chest X-ray: bilateral, diffuse, patchy densities concentrated in the lower lung fields. This reflects bleeding into the lung tissue, which is one of the most dangerous complications.
Abdominal ultrasound may reveal an enlarged liver, and heart ultrasound occasionally picks up a small pericardial effusion (fluid around the heart). These findings aren’t specific to leptospirosis, but in the right clinical context they support the diagnosis and help gauge severity.
Culture: Definitive but Impractical
Growing the bacteria in culture provides a definitive diagnosis and is the only way to identify the exact strain. However, Leptospira is extremely slow-growing and fastidious. It requires specialized liquid media kept at 29 to 32 degrees Celsius with supplemental carbon dioxide. Even under ideal conditions, cultures can take weeks to turn positive, making them useless for guiding treatment in real time. Culture is primarily a research and public health surveillance tool.
How Cases Are Officially Classified
The CDC’s 2025 case definition lays out a clear hierarchy. A confirmed case requires at least one of the following: isolation of the bacteria from a clinical specimen, a fourfold antibody rise between paired samples, a MAT titer of 800 or higher on a single sample, detection of pathogenic Leptospira DNA by PCR, or demonstration of the bacteria in tissue by immunofluorescence.
A probable case requires compatible symptoms plus either presumptive lab evidence (a MAT titer between 200 and 800, positive IgM antibodies, or visualization of spirochetes under darkfield microscopy) or an epidemiologic link to a known outbreak or exposure event such as a flood, adventure race, or occupational contact with animals.
Choosing the Right Test at the Right Time
The practical takeaway is that timing determines which test to use. During the first week of symptoms, PCR on blood or urine is the most sensitive approach. After the first week, antibody-based tests (MAT, IgM ELISA, or rapid tests) become more reliable because the immune response has had time to build. The strongest confirmation comes from paired MAT samples drawn two to six weeks apart, but waiting for that second sample shouldn’t delay treatment if clinical suspicion is high.
If you’re being evaluated, expect your doctor to order a combination of tests rather than relying on any single one. A PCR plus an acute-phase antibody test covers both diagnostic windows and gives the best chance of catching the infection regardless of when in the illness you happen to seek care.